These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 16546726)
1. [Adenovirus-mediated delivery of targeted ribonuclease against HBV replication in vitro]. Gong WD; Lei P; Zhao Y; Liu J; Xue CF Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):279-83. PubMed ID: 16546726 [TBL] [Abstract][Full Text] [Related]
2. Anti-HBV activity of TRL mediated by recombinant adenovirus. Gong WD; Zhao Y; Yi J; Ding J; Liu J; Xue CF World J Gastroenterol; 2005 May; 11(17):2574-8. PubMed ID: 15849814 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of HBV targeted ribonuclease enhanced by introduction of linker. Gong WD; Liu J; Ding J; Zhao Y; Li YH; Xue CF World J Gastroenterol; 2003 Jul; 9(7):1504-7. PubMed ID: 12854151 [TBL] [Abstract][Full Text] [Related]
4. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter]. Zhou HK; Yang DH; Tang SH; Huang W; Lu XH Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715 [TBL] [Abstract][Full Text] [Related]
5. Adenoviral-vector mediated transfer of HBV-targeted ribonuclease can inhibit HBV replication in vivo. Zhao Y; Li Y; Liu J; Liu Z; Huang Y; Lei J; Li S; Xue C Biochem Biophys Res Commun; 2008 Jul; 371(3):541-5. PubMed ID: 18455508 [TBL] [Abstract][Full Text] [Related]
6. [Construction of replication-deficient recombinant adenoviral vector carrying HBsAg and HSP70 chimeric gene and its expression in vitro]. Lei CL; Huang CH; Yang Z; Tang XP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):136-9. PubMed ID: 18574539 [TBL] [Abstract][Full Text] [Related]
7. [Expression of HBV preS2/S gene in mammalian cells transferred with adenoviral vector]. Lei CL; Huang CH; Yang Z; Tang XP Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):55-7. PubMed ID: 16201475 [TBL] [Abstract][Full Text] [Related]
8. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells. Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586 [TBL] [Abstract][Full Text] [Related]
9. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells]. Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716 [TBL] [Abstract][Full Text] [Related]
10. [Construction and expression of prokaryotic expression vector for pTAT-HBV targeted ribonuclease fusion protein]. Ding J; Liu J; Xue CF; Li YH; Gong WD Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):49-51. PubMed ID: 15132905 [TBL] [Abstract][Full Text] [Related]
11. [Adenovirus-mediated transduction of HBV/C genome into HepG2 cell line]. Zhou B; Liang MF; Li WD; Wang C; Wang ZH; Hou JL Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1764-7. PubMed ID: 18971166 [TBL] [Abstract][Full Text] [Related]
12. Targeted ribonuclease can inhibit replication of hepatitis B virus. Liu J; Li YH; Xue CF; Ding J; Gong WD; Zhao Y; Huang YX World J Gastroenterol; 2003 Feb; 9(2):295-9. PubMed ID: 12532452 [TBL] [Abstract][Full Text] [Related]
13. [Inhibition of HBsAg and HBeAg secretion by RNA interference of the polymerase gene sequence of hepatitis B virus: an experimental study]. Liu SA; Wei HS; Dong QM; Guo JJ; Qin J; Zhang QY; Liu ZY; Yan J; Cheng J Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3079-83. PubMed ID: 16324412 [TBL] [Abstract][Full Text] [Related]
14. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector]. Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133 [TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter]. Wang Y; Jiang D; Wei L; Chen HS; Cong X; Fei R; Wang Y Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):218-22. PubMed ID: 15640852 [TBL] [Abstract][Full Text] [Related]
16. [Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2 cells]. Tang N; Huang AL; Zhang BQ; Yan G; Xiang MQ; Pu D; Guo H Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):464-6. PubMed ID: 12939176 [TBL] [Abstract][Full Text] [Related]
17. A promising alternative anti-HBV agent: the targeted ribonuclease. Li Y; Zhao Y; Liu J; Huang Y; Liu Z; Xue C Int J Mol Med; 2010 Jul; 26(1):51-6. PubMed ID: 20514422 [TBL] [Abstract][Full Text] [Related]
18. [Construction of a recombinant adenovirus expression vector for human renal tumor- associated antigen G250 gene with AdMax system]. Qi H Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1617-20, 1625. PubMed ID: 18819881 [TBL] [Abstract][Full Text] [Related]
19. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell. Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501 [TBL] [Abstract][Full Text] [Related]
20. [Stable expression of HBV C gene mutants in immortalized human B-cell lines]. Zhang MX; Zhou FY; Diao ZH; He HT; Hou JL; Luo KX Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):725-9. PubMed ID: 16793585 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]